What are the major opportunities in the Cannabis Pharmaceuticals market? What are the strategies for the Cannabis Pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Cannabis Pharmaceuticals market, Read More

How does the Cannabis Pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Cannabis Pharmaceuticals's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Cannabis Pharmaceuticals market growth? SWOT analysis of the Cannabis Pharmaceuticals market.

For detailed insights on the key dynamics influencing the Cannabis Pharmaceuticals market growth and SWOT analysis of the Cannabis Pharmaceuticals industry, Read More

Global Cannabis Pharmaceuticals Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Cannabis Pharmaceuticals Global Market Report 2025

Name: Cannabis Pharmaceuticals Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids), By Formulation Type (Capsules And Tablets, Oils And Tinctures, Topical Solutions ), By Therapeutic Application (Cancer, Neurological Disorders, Pain Management), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-User (Hospitals And Clinics, Rehabilitation Centers, Research Organizations) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cannabis Pharmaceuticals Market Overview

• Cannabis Pharmaceuticals market size has reached to $6.03 billion in 2024

• Expected to grow to $55.53 billion in 2029 at a compound annual growth rate (CAGR) of 55.8%

• Growth Driver: Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments

• Market Trend: Advancing Medical Cannabis Production To Meet Global Demand

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cannabis Pharmaceuticals Market?

Cannabis pharmaceuticals are prescription-grade medications made from cannabis-derived compounds, designed to address particular health conditions and produced under strict clinical and regulatory standards. These pharmaceuticals utilize the therapeutic benefits of cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), to treat conditions including chronic pain, epilepsy, and multiple sclerosis.

The main indications in the cannabis pharmaceuticals include cannabinoid-based pharmaceuticals, Cannabis Extracts, and synthetic cannabinoids. Cannabinoid-based pharmaceuticals are drugs that incorporate synthetic or natural cannabinoids, such as THC and CBD, to address various health conditions. The various formulation types are capsules and tablets, oils and tinctures, and topical solutions used in therapeutic applications such as cancer, neurological disorders, and pain management. The various distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies and are used by several end users, including hospitals and clinics, rehabilitation centers, and research organizations.

Cannabis Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

What Is The Cannabis Pharmaceuticals Market Size 2025 And Growth Rate?

What Is The Cannabis Pharmaceuticals Market Growth Forecast?

The cannabis pharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $55.53 billion in 2029 at a compound annual growth rate (CAGR) of 55.8%. The growth in the forecast period can be attributed to increasing regulatory approvals, growing awareness of medical cannabis benefits, expanding applications in pain and neurological disorder management, rising prevalence of chronic illnesses, innovations in drug delivery systems, and the establishment of favorable reimbursement policies. Major trends in the forecast period include advancements in cannabinoid extraction technologies, development of targeted drug delivery systems, adoption of synthetic cannabinoid formulations, improved clinical trial methodologies, and integration of artificial intelligence for drug discovery.

The forecast of 55.8% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug development by increasing the cost of Food and Drug Administration(FDA)-approved cannabis-derived Active Pharmaceutical Ingredients(APIs) and standardized formulations sourced from Canada and Israel, thereby delaying neurological treatment availability and elevating pharmaceutical R&D costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cannabis Pharmaceuticals Market Segmented?

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids

2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions

3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)

3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids

What Is Driving The Cannabis Pharmaceuticals Market? Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments

The rise in incidence of epilepsy is expected to drive the cannabis pharmaceuticals market going forward. Epilepsy refers to a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. The rise in epilepsy cases can be attributed to better diagnosis, increased awareness, and enhanced reporting, alongside potential environmental, genetic, and lifestyle influences. Cannabis pharmaceuticals have shown potential in helping manage epilepsy by utilizing cannabinoids like CBD to reduce the frequency and severity of seizures in patients who do not respond well to traditional anti-epileptic drugs. For instance, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally, including 65 million with epilepsy. Moreover, in July 2024, according to the Alzheimer Society of Canada, a Canada-based health charity, according to estimates, 771,939 Canadians are expected to have dementia on January 1, 2025, and by 2030, that number is predicted to rise to nearly one million. Therefore, the rise in incidence of epilepsy is driving the growth of the cannabis pharmaceuticals industry.

Who Are The Major Players In The Global Cannabis Pharmaceuticals Market?

Major companies operating in the cannabis pharmaceuticals market are Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte's Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.

What Are The Key Trends Of The Global Cannabis Pharmaceuticals Market? Advancing Medical Cannabis Production To Meet Global Demand

Major companies operating in the cannabis pharmaceuticals market are focusing on developing innovative products such as advanced medical cannabis formulations to address a range of medical conditions and improve patient outcomes. Advanced medical cannabis formulations refer to specially designed cannabis-based products that are optimized for therapeutic use, incorporating precise doses of cannabinoids like THC and CBD. For instance, in April 2024, Canexis Pharma AG, a Switzerland-based pharmaceutical company, received manufacturing and narcotics licenses from Swissmedic for cannabis pharmaceuticals. These approvals empower the company to produce premium-grade medicinal active ingredients derived from CBD and THC. This development positions Canexis to meet the growing demand for medical cannabis both within Switzerland and globally. By obtaining these licenses, the company demonstrates its compliance with stringent regulatory standards, enhancing its credibility and ability to contribute to the rapidly evolving medical cannabis market.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cannabis Pharmaceuticals Market? Strategic Acquisition Expands Flora Growth's Global Capabilities

In December 2022, Flora Growth Corp., a US-based cannabis products manufacturing company, acquired Franchise Global Health Inc. for an amount of $19.5 million. The acquisition strengthens Flora's global reach, expanding its EU distribution network and client base, with a key focus on Germany's growing cannabis market. Additionally, it enhances Flora's capacity to meet rising medical and pharmaceutical cannabis demand. Franchise Global Health Inc. is a Canada-based pharmaceutical company primarily engaged in the medical cannabis and pharmaceutical industries.

What Is The Regional Outlook For The Global Cannabis Pharmaceuticals Market?

North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cannabis Pharmaceuticals Market?

The cannabis pharmaceuticals market consists of sales of dronabinol (synthetic THC) and cannabidiol (CBD) oil used to treat various medical conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cannabis Pharmaceuticals Industry?

The cannabis pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cannabis Pharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.43 billion
Revenue Forecast In 2034	$55.53 billion
Growth Rate	CAGR of 55.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The cannabis pharmaceuticals market covered in this report is segmented – 1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids 2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions 3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management 4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies 5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations Subsegments: 1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations 2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate) 3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte's Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cannabis Pharmaceuticals Market Characteristics

3. Cannabis Pharmaceuticals Market Trends And Strategies

4. Cannabis Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cannabis Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Cannabis Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cannabis Pharmaceuticals Market Growth Rate Analysis

5.4. Global Cannabis Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cannabis Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cannabis Pharmaceuticals Total Addressable Market (TAM)

6. Cannabis Pharmaceuticals Market Segmentation

6.1. Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cannabinoid-Based Pharmaceuticals

Cannabis Extracts

Synthetic Cannabinoids

6.2. Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Capsules And Tablets

Oils And Tinctures

Topical Solutions

6.3. Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Neurological Disorders

Pain Management

6.4. Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

6.5. Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Rehabilitation Centers

Research Organizations

6.6. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

THC-Based Pharmaceuticals

CBD-Based Pharmaceuticals

Combination of THC and CBD Pharmaceuticals

Other Cannabinoid-Based Formulations

6.7. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Full-Spectrum Cannabis Extracts

Broad-Spectrum Cannabis Extracts

Isolate Cannabis Extracts (CBD Isolate)

6.8. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Synthetic THC Analogues

Synthetic CBD Analogues

Synthetic Cannabinoid Receptor Agonists

Designer Synthetic Cannabinoids

7. Cannabis Pharmaceuticals Market Regional And Country Analysis

7.1. Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cannabis Pharmaceuticals Market

8.1. Asia-Pacific Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cannabis Pharmaceuticals Market

9.1. China Cannabis Pharmaceuticals Market Overview

9.2. China Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cannabis Pharmaceuticals Market

10.1. India Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cannabis Pharmaceuticals Market

11.1. Japan Cannabis Pharmaceuticals Market Overview

11.2. Japan Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cannabis Pharmaceuticals Market

12.1. Australia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cannabis Pharmaceuticals Market

13.1. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cannabis Pharmaceuticals Market

14.1. South Korea Cannabis Pharmaceuticals Market Overview

14.2. South Korea Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cannabis Pharmaceuticals Market

15.1. Western Europe Cannabis Pharmaceuticals Market Overview

15.2. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cannabis Pharmaceuticals Market

16.1. UK Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cannabis Pharmaceuticals Market

17.1. Germany Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cannabis Pharmaceuticals Market

18.1. France Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cannabis Pharmaceuticals Market

19.1. Italy Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cannabis Pharmaceuticals Market

20.1. Spain Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cannabis Pharmaceuticals Market

21.1. Eastern Europe Cannabis Pharmaceuticals Market Overview

21.2. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cannabis Pharmaceuticals Market

22.1. Russia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cannabis Pharmaceuticals Market

23.1. North America Cannabis Pharmaceuticals Market Overview

23.2. North America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cannabis Pharmaceuticals Market

24.1. USA Cannabis Pharmaceuticals Market Overview

24.2. USA Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cannabis Pharmaceuticals Market

25.1. Canada Cannabis Pharmaceuticals Market Overview

25.2. Canada Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cannabis Pharmaceuticals Market

26.1. South America Cannabis Pharmaceuticals Market Overview

26.2. South America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cannabis Pharmaceuticals Market

27.1. Brazil Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cannabis Pharmaceuticals Market

28.1. Middle East Cannabis Pharmaceuticals Market Overview

28.2. Middle East Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cannabis Pharmaceuticals Market

29.1. Africa Cannabis Pharmaceuticals Market Overview

29.2. Africa Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cannabis Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Cannabis Pharmaceuticals Market Competitive Landscape

30.2. Cannabis Pharmaceuticals Market Company Profiles

30.2.1. Curaleaf Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Aphria Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Green Thumb Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Trulieve Cannabis Corp. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cannabis Pharmaceuticals Market Other Major And Innovative Companies

31.1. Cresco Labs Inc.

31.2. Columbia Care Inc.

31.3. Acreage Holdings Inc.

31.4. Canopy Growth Corporation

31.5. Aurora Cannabis Inc.

31.6. MedMen Enterprises Inc.

31.7. OrganiGram Holdings Inc.

31.8. Cronos Group

31.9. Enveric Biosciences Inc.

31.10. Auxly Cannabis Group Inc.

31.11. Valens Company Inc.

31.12. Charlotte's Web Holdings Inc.

31.13. Medical Marijuana Inc.

31.14. Aleafia Health Inc.

31.15. Supreme Cannabis Company Inc.

32. Global Cannabis Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabis Pharmaceuticals Market

34. Recent Developments In The Cannabis Pharmaceuticals Market

35. Cannabis Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Cannabis Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Cannabis Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Cannabis Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Curaleaf Holdings Inc. Financial Performance

Table 80: Aphria Inc. Financial Performance

Table 81: Green Thumb Industries Inc. Financial Performance

Table 82: Trulieve Cannabis Corp. Financial Performance

Table 83: Tilray Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Curaleaf Holdings Inc. Financial Performance

Figure 80: Aphria Inc. Financial Performance

Figure 81: Green Thumb Industries Inc. Financial Performance

Figure 82: Trulieve Cannabis Corp. Financial Performance

Figure 83: Tilray Inc. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Cannabis Vaporizers Global Market Report 2025 – By Type (Portable, Tabletop), By Ingredients (Herbs, Oils, Cannabis Wax ), By Heating Method (Conduction, Convection, Induction), By Purpose (Medical Purpose, Recreational ...

Medical Marijuana Global Market Report 2025 – By Product (Dried Flower, Extract Form), By Type (Flower, Concentrate, Edibles, Other Types), By Application (Pain Management, Tourette Syndrome, Alzheimer's disease, Migrain...

Recreational Cannabis Global Market Report 2025 – By Product (Oils, Transdermal Patches, Tablets, Capsule, Vape, Suppositories, Tinctures, Creams, Edibles, Other Products ), By Compound (Tetrahydrocannabinol (THC) Domina...

Cannabinoids Global Market Report 2025 – By Product Type (Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types), By Distribution (Hospital Pharmacies, Retail Pharmacies, Online Stores ), By Application (Med...

Cannabis Extract Global Market Report 2025 – By Product Type (Oils, Tinctures), By Extract Type (Full Spectrum Extracts, Cannabis Isolates), By Sources (Hemp, Marijuana), By Distribution Channel (Hospital Pharmacies, Ret...

Cannabis Capsule Global Market Report 2025 – By Type (High Tetrahydrocannabinol Capsules, Tetrahydrocannabinol Or Cannabinol Balance Capsule, High Cannabinol Capsules), By Compound (Tetrahydrocannabinol (THC)-Dominant, C...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Frequently Asked Questions

What is the definition of the Cannabis Pharmaceuticals market?

How will the Cannabis Pharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Cannabis Pharmaceuticals industry going forward?

The market major growth driver - Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Cannabis Pharmaceuticals market?

The cannabis pharmaceuticals market size has grown exponentially in recent years. It will grow from $6.03 billion in 2024 to $9.43 billion in 2025 at a compound annual growth rate (CAGR) of 56.4%. The growth in the historic period can be attributed to increase in legalization of medical cannabis, rise in awareness of cannabinoid therapeutic benefits, growth in prevalence of chronic and neurological disorders, supportive regulatory frameworks, expanding pharmaceutical investments, and shift in public perception toward cannabis use in healthcare. The cannabis pharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to " $55.53 billion in 2029 at a compound annual growth rate (CAGR) of 55.8%. The growth in the forecast period can be attributed to increasing regulatory approvals, growing awareness of medical cannabis benefits, expanding applications in pain and neurological disorder management, rising prevalence of chronic illnesses, innovations in drug delivery systems, and the establishment of favorable reimbursement policies. Major trends in the forecast period include advancements in cannabinoid extraction technologies, development of targeted drug delivery systems, adoption of synthetic cannabinoid formulations, improved clinical trial methodologies, and integration of artificial intelligence for drug discovery. For further insights on this market, request a sample here

How is the Cannabis Pharmaceuticals market segmented?

The cannabis pharmaceuticalsmarket covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals; Cannabis Extracts; Synthetic Cannabinoids
2) By Formulation Type: Capsules And Tablets; Oils And Tinctures; Topical Solutions
3) By Therapeutic Application: Cancer; Neurological Disorders; Pain Management
4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
5) By End-User: Hospitals And Clinics; Rehabilitation Centers; Research Organizations Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals; CBD-Based Pharmaceuticals; Combination of THC and CBD Pharmaceuticals; Other Cannabinoid-Based Formulations
2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts; Broad-Spectrum Cannabis Extracts; Isolate Cannabis Extracts (CBD Isolate)
3) By Synthetic Cannabinoids: Synthetic THC Analogues; Synthetic CBD Analogues; Synthetic Cannabinoid Receptor Agonists; Designer Synthetic Cannabinoids For further insights on this market, request a sample here

Which region has the largest share of the Cannabis Pharmaceuticals market? What are the other regions covered in the report?

North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Cannabis Pharmaceuticals market?

What are the key trends in the Cannabis Pharmaceuticals market?

Major trends in this market include Advancing Medical Cannabis Production To Meet Global Demand. For further insights on this market, request a sample here.